GMP supply Zanubrutinib
GMP ISO COA
1691249-45-2
Pharmaceutical Grade
99%
BJ
Drum
2025-10-30
Weight Loss Peptide,Reta,Tirz,Sema,5 Amino 1mq,Cosmetic raw material,API,SLU-PP-332
-
Product Description
-
Seller Information
-
DescriptionCertificatesBasic Info
-
Product Name:
Zanubrutinib
Other Name:Zanubrutinib;anubrutinib;BGB-3111(Zanubrutinib);The BTK inhibitor;Zanubrutinib (BGB-3111);BGB-3111;ZANUBRUTINIB;BGB 3111;BGB3111;(S)-7-(1-Acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide;Pyrazolo[1,5-a]pyrimidine-3-carboxamide, 4,5,6,7-tetrahydro-7-[1-(1-oxo-2-propen-1-yl)-4-piperidinyl]-2-(4-phenoxyphenyl)-, (7S)-
CAS No.:1691249-45-2
Molecular Formula:C27H29N5O3
InChIKeys:RNOAOAWBMHREKO-QFIPXVFZSA-N
Molecular Weight:471.55
Exact Mass:471.55
EC Number:202-303-5
UNII:AG9MHG098Z
NCI Thesaurus Code:C141428
Color/Form:White to off-white
ATC Code:L - Antineoplastic and immunomodulating agents
Categories:
Characteristics-
Density:
1.33±0.1 g/cm3(Predicted)
Boiling Point:713.4±60.0 °C(Predicted)
PKA:15.35±0.40(Predicted)
Critical Temperature & Pressure:Store at -20°C
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Weight Loss Peptide,Reta,Tirz,Sema,5 Amino 1mq,Cosmetic raw material,API,SLU-PP-332
-
Location:
Unit D01,3/F., Wong King Industrial Building,No.2 Tai Yau Street, Kowloon
-
Payment Terms:
TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
7
-
Total Annual Revenue:
$50 million-$100 million
-
Total Employees:
51-100
-
Year of Establishment:
2012
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product